Dear NYS COVID-19 Vaccine Provider:
This email includes updated information about submission of weekly planning requests (“prebook requests”) for COVID-19 vaccine for your provider location enrolled in the NYSDOH COVID-19 Vaccine Program to include Janssen (Johnson and Johnson) vaccine. The requests are always due by 5 pm each Monday and must be data entered in NYSIIS on Monday (and not in advance). If your facility location is closed on all or any Mondays, please ensure that a designated staff person is identified to perform the data entry each Monday. The system is accessible remotely from any computer. This is necessary due to the timing of when NYSDOH must make allocation decisions and place orders.
Beginning March 1, 2021, in addition to Pfizer and Moderna vaccines, you will be able to submit a planning request for Janssen vaccine (Johnson and Johnson). Janssen vaccine is a single-dose vaccine that will be transported and stored at refrigerated temperatures (36 to 46 degrees Fahrenheit or 2 to 8 degrees Celsius). A product summary for each vaccine is listed below.
The entire planning request amount (combination of Pfizer + Moderna + Janssen) must not exceed the total overall amount you are able to store and administer to eligible populations within seven days from receipt. The planning request amounts must be entered in multiples of the minimum shipping quantity for each product.
Share
FDA Authorizes Updated (Bivalent) COVID-19 Vaccines for Children Down to 6 Months of Age – December 9, 2022 Dear COVID-19 Vaccination Provider: On December 8, 2022, FDA authorized the bivalent Moderna COVID-19 vaccine for children ages 6 months through 5 years of age and bivalent Pfizer-BioNTech COVID-19 vaccine for children 6 months through 4 […]
Yesterday, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-bivalent-covid-19-vaccines. CDC’s Director Dr. Rochelle Walensky released a statement and signed a decision memo recommending updated (bivalent) COVID-19 boosters for children five years and older. This expands on CDC's recommendation issued September 1, 2022, for updated COVID-19 boosters of people ages 12 and older.
Updated Clinical Guidance For Individuals 6 Months-11 Years Old – June 22, 2022 Dear NYS COVID-19 Vaccine Provider: Effective June 18, 2022, the CDC has recommended that everyone ages 6 months and older in the United States should receive a COVID-19 primary series vaccination for the prevention of COVID-19. This attached provider guidance has […]
Updated Guidance for The New York State COVID-19 Vaccination Program for Individuals 12 Years of Age or Older June 13, 2022 Note: This guidance document applies specifically to health care providers offering COVID-19 vaccinations to adolescents and adults ages 12 and older. Guidance specific to COVID-19 vaccination of children ages 5-11 can be found […]
